Tag: sirna transfection reagents
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
The emergence of the coronavirus 2019 (COVID-19) pandemic has offered an unprecedented world problem. Vaccines in opposition to COVID have been developed so far. Covid-19 has been linked with the event of Guillain-Barre Syndrome (GBS), a uncommon immune-mediated demyelinating neuropathy. We report three circumstances of Guillain-Barre Syndrome and one case of Power Inflammatory Demyelinating Polyneuropathy…Read More